AWS has expanded Amazon CloudWatch to unify log management across operational and security use cases. By integrating native ...
York, Pa.-based WellSpan Health is migrating its entire technology infrastructure to the cloud through a partnership with Amazon Web Services. The health system will transition its applications, data ...
Amazon Web Services and Ripple are reportedly researching the use of Amazon Bedrock’s generative artificial intelligence (Gen ...
APLD Q2 2026 earnings call highlights: hyperscale leases, 600MW AI data centers, 250% revenue jump & $1B NOI goal.
Palantir grew revenue 63% with 51% operating margins and $540M in free cash flow. Snowflake grew 29% but posted a negative 27% operating margin and lost $329M operationally. Palantir trades at 112x ...
The Army Transformation Initiative (ATI) demands a leaner, more efficient force. A critical component of this transformation is addressing the growing backlog of excess repair parts that weigh down ...
Cohesity, a leader in AI-powered data security, announced that it has signed a strategic collaboration agreement (SCA) with Amazon Web Services, Inc. (AWS), expanding its use of advanced AWS ...
Nov 3 (Reuters) - Verizon (VZ.N), opens new tab announced a deal with Amazon Web Services on Monday to build high-capacity fiber routes connecting AWS data centers, aiming to strengthen infrastructure ...
Amazon CFO Brian Olsavsky shared that the company has increased its full-year capital expenditure projections to $125 billion. The company had previously guided for $100 billion in the June quarter.
Part of Amazon's massive data center project near New Carlisle, Indiana, is now operational. The complex, a partnership with Anthropic, has begun training and running artificial intelligence models.
Amazon Web Services Inc. has opened a $11 billion data center campus in Indiana that will run artificial intelligence models for Anthropic PBC. CNBC reported the milestone today. The campus, which is ...
Aldeyra Therapeutics has shaken up its drug development pipeline, stopping work on one asset in the wake of phase 2 data and swapping out two other molecules in response to recent results. The biotech ...